{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T12:42:27Z","timestamp":1742388147771},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10165-011-0534-4","type":"journal-article","created":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T00:41:42Z","timestamp":1317775302000},"page":"382-393","source":"Crossref","is-referenced-by-count":8,"title":["Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial"],"prefix":"10.1093","volume":"22","author":[{"given":"Nobuyuki","family":"Miyasaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Additional Members of the GB-0998 Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eizo","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,10,5]]},"reference":[{"key":"534_CR1","first-page":"351","volume":"17","author":"WG Bradley","year":"1977","unstructured":"Bradley WG. Polymyositis. Br J Hosp Med. 1977;17:351\u20135.","journal-title":"Br J Hosp Med"},{"key":"534_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003495-199754010-00003","volume":"54","author":"P Cherin","year":"1997","unstructured":"Cherin P. Recognition and management of myositis. Drugs. 1997;54:39\u201349.","journal-title":"Drugs"},{"key":"534_CR3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344\u20137.","journal-title":"N Engl J Med"},{"key":"534_CR4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10165-003-0250-9","volume":"13","author":"M Hara","year":"2003","unstructured":"Hara M, Kinoshita M, Saito E, Hashimoto H, Miyasaka N, Yoshida T, et\u00a0al. Prospective study of high-dose intravenous immunoglobulin for the treatment of steroid-resistant polymyositis and dermatomyositis. Mod Rheumatol. 2003;13:319\u201325.","journal-title":"Mod Rheumatol"},{"key":"534_CR5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10165-007-0013-0","volume":"18","author":"E Saito","year":"2008","unstructured":"Saito E, Koike T, Hashimoto H, Miyasaka N, Ikeda Y, Hara M, et\u00a0al. Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis. Mod Rheumatol. 2008;18:34\u201344.","journal-title":"Mod Rheumatol"},{"key":"534_CR6","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, et\u00a0al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 1993;329:1993\u20132000.","journal-title":"N Engl J Med"},{"key":"534_CR7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.1987.03400040111034","volume":"258","author":"CM Roifman","year":"1987","unstructured":"Roifman CM, Schaffer FM, Wachsmuth SE, Murphy G, Gelfand EW. Reversal of chronic polymyositis following intravenous immune serum globulin therapy. JAMA. 1987;258:513\u20135.","journal-title":"JAMA"},{"key":"534_CR8","unstructured":"Dalakas MC. Polymyositis, dermatomyositis, and inclusion body myositis. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et\u00a0al., editors. Harrison\u2019s principles of internal medicine. 17th ed. New York: McGraw-Hill; 2008. p. 2696\u2212703."},{"key":"534_CR9","unstructured":"Aberer W, Bagot M, Braathen L, Chimenti S, Diaz-Perez JL, Hegyi V, et\u00a0al. Guidelines on the use of high-dose intravenous immunoglobulin in dermatology. European dermatology forum. Available at: http:\/\/www.euroderm.org\/edf\/images\/stories\/guidelines\/guideline_on_ivig-aktuell-neu-2008.pdf . Cited 9 March 2010."},{"key":"534_CR10","doi-asserted-by":"crossref","unstructured":"EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases\/EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol. 2008;15:893\u2212908.","DOI":"10.1111\/j.1468-1331.2008.02246.x"},{"key":"534_CR11","first-page":"263","volume":"14","author":"YM Maugars","year":"1996","unstructured":"Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol. 1996;14:263\u201374.","journal-title":"Clin Exp Rheumatol"},{"key":"534_CR12","first-page":"2230","volume":"28","author":"I Marie","year":"2001","unstructured":"Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, et\u00a0al. Polymyositis and dermatomyositis:short term and longterm outcome, and predictive factors of prognosis. J Rheumatol. 2001;28:2230\u20137.","journal-title":"J Rheumatol"},{"key":"534_CR13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4065\/82.4.441","volume":"82","author":"TH Oh","year":"2007","unstructured":"Oh TH, Brumfield KA, Hoskin TL, Stolp KA, Murray JA, Bassford JR. Dysphagia in inflammatory myopathy:clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc. 2007;82:441\u20137.","journal-title":"Mayo Clin Proc"},{"key":"534_CR14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.42.1.257","volume":"42","author":"PL Silbert","year":"1992","unstructured":"Silbert PL, Knezevic WV, Bridge DT. Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis. Neurology. 1992;42:257\u20138.","journal-title":"Neurology"},{"key":"534_CR15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.44.2.223","volume":"44","author":"MC Dalakas","year":"1994","unstructured":"Dalakas MC. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology. 1994;44:223\u20136.","journal-title":"Neurology"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0534-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:27:50Z","timestamp":1646843270000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0534-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,5]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0534-4","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,5]]}}}